253 related articles for article (PubMed ID: 24415778)
21. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
22. Intracellular osteopontin regulates homeostasis and function of natural killer cells.
Leavenworth JW; Verbinnen B; Wang Q; Shen E; Cantor H
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):494-9. PubMed ID: 25550515
[TBL] [Abstract][Full Text] [Related]
23. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner.
Guo S; Cobb D; Smeltz RB
J Immunol; 2009 May; 182(10):6179-86. PubMed ID: 19414771
[TBL] [Abstract][Full Text] [Related]
24. Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells.
Miyazato K; Tahara H; Hayakawa Y
Cancer Sci; 2020 Aug; 111(8):2770-2778. PubMed ID: 32573072
[TBL] [Abstract][Full Text] [Related]
25. Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation.
Robbins SH; Tessmer MS; Van Kaer L; Brossay L
Eur J Immunol; 2005 Mar; 35(3):757-65. PubMed ID: 15719366
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
Hirschowitz EA; Crystal RG
Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
[TBL] [Abstract][Full Text] [Related]
27. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
[TBL] [Abstract][Full Text] [Related]
28. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein.
Ochoa MC; Fioravanti J; Rodriguez I; Hervas-Stubbs S; Azpilikueta A; Mazzolini G; Gúrpide A; Prieto J; Pardo J; Berraondo P; Melero I
Cancer Res; 2013 Jan; 73(1):139-49. PubMed ID: 23149919
[TBL] [Abstract][Full Text] [Related]
29. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis.
Fort MM; Leach MW; Rennick DM
J Immunol; 1998 Oct; 161(7):3256-61. PubMed ID: 9759840
[TBL] [Abstract][Full Text] [Related]
30. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12.
Schulz EG; Mariani L; Radbruch A; Höfer T
Immunity; 2009 May; 30(5):673-83. PubMed ID: 19409816
[TBL] [Abstract][Full Text] [Related]
31. Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine model.
Seth R; Tai LH; Falls T; de Souza CT; Bell JC; Carrier M; Atkins H; Boushey R; Auer RA
Ann Surg; 2013 Jul; 258(1):158-68. PubMed ID: 23108132
[TBL] [Abstract][Full Text] [Related]
32. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
[TBL] [Abstract][Full Text] [Related]
33. In vivo tumor suppression activity by T cell-specific T-bet restoration.
Lee K; Min HJ; Jang EJ; Hong JH; Hwang ES
Int J Cancer; 2010 Nov; 127(9):2129-37. PubMed ID: 20143391
[TBL] [Abstract][Full Text] [Related]
34. The transcription factor T-bet is induced by IL-15 and thymic agonist selection and controls CD8αα(+) intraepithelial lymphocyte development.
Klose CS; Blatz K; d'Hargues Y; Hernandez PP; Kofoed-Nielsen M; Ripka JF; Ebert K; Arnold SJ; Diefenbach A; Palmer E; Tanriver Y
Immunity; 2014 Aug; 41(2):230-43. PubMed ID: 25148024
[TBL] [Abstract][Full Text] [Related]
35. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles.
Goldfarb RH; Kitson RP; Brunson KW; Yoshino K; Hirota N; Kirii Y; Kotera Y; Inoue Y; Ohashi M
Anticancer Res; 1999; 19(3A):1663-7. PubMed ID: 10470098
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
37. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
39. IL-12/15/18-preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation.
Hüber CM; Doisne JM; Colucci F
Eur J Immunol; 2015 Jun; 45(6):1727-35. PubMed ID: 25778912
[TBL] [Abstract][Full Text] [Related]
40. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
